Blog
RSS FeedPosted by Michael Wonder on 25 Apr 2023
Major PBS shake-up will allow Australians to purchase more medicine for less, saving buyers $1.6 billion
25 April 2023 - Millions of Australians will be able to buy 60 days' worth of medicine for the price of ...
Posted by Michael Wonder on 24 Apr 2023
Changes to treatment phases and authority levels in medicines for the treatment of Alzheimer’s disease
24 April 2023 - From 1 May 2023, the PBS item codes for donepezil, galantamine, memantine and rivastigmine, for the treatment ...
Posted by Michael Wonder on 23 Apr 2023
Pharmacists warn PBS changes risk medicines shortage
21 April 2023 - Pharmacists have warned that millions of Australians face extreme medicine shortages and months-long wait times under ...
Posted by Michael Wonder on 21 Apr 2023
Recommendations made by the PBAC (March 2023)
21 April 2023 - Recommendations made by the PBAC in March 2023 relating to the listing of medicines on the Pharmaceutical ...
Posted by Michael Wonder on 21 Apr 2023
Publication of stage 1 and stage 2 PBS process improvements metrics report (2021-22)
21 April 2023 - The 2021-22 Stage 1 and Stage 2 PBS process improvements metrics report is now available. ...
Posted by Michael Wonder on 20 Apr 2023
AMA urges pharmacy reform to deliver lower medicine prices
20 April 2023 - The AMA says it’s high time recommendations from more than a dozen expert reports and inquiries over ...
Posted by Michael Wonder on 20 Apr 2023
Updates from the Health Technology Assessment Policy and Methods Review Reference Committee – March and April 2023
20 April 2023 - The Health Technology Assessment Policy and Methods Review Reference Committee met on 24 March 2023 and ...
Posted by Michael Wonder on 16 Apr 2023
Price of a life: Australians wait two years longer for breakthrough medicines than US citizens
16 April 2023 - Australians are waiting two years longer to access new lifesaving subsidised medicines because of pharma giants. Now, ...
Posted by Michael Wonder on 16 Apr 2023
Australian cancer patients spend $200 million a year on treatments not on the PBS and it’s got to change
16 April 2023 - Australian cancer patients were spending in excess of $200m each year of their own money on therapies ...
Posted by Michael Wonder on 12 Apr 2023
HTA reform starts today – consultations open
11 April 2023 - Medicines Australia welcomes the official start of the Health Technology Assessment (HTA) Review consultation that should ...
Posted by Michael Wonder on 11 Apr 2023
Health technology assessment policy and methods review consultation
11 April 2023 - The first round of public consultation for the HTA Review is open. Submissions will be accepted ...
Posted by Michael Wonder on 11 Apr 2023
New life saving medicines
11 April 2023 - The Australian Government has added the two medicines, Kanuma (sebelipase alfa) and Cerdelga (eliglustat) to the Life ...
Posted by Michael Wonder on 10 Apr 2023
Cheaper medicines for graft versus host disease, chronic rhinosinusitis and oesophageal cancer
10 April 2023 - For the first time Jakavi (ruxolitinib) will be listed for the treatment of patients with either acute ...
Posted by Michael Wonder on 06 Apr 2023
Public summary documents – December 2022 PBAC meeting
6 April 2023 - The public summary documents (positive recommendations and subsequent decisions not to recommend) from the December 2022 PBAC ...
Posted by Michael Wonder on 06 Apr 2023
Life changing cystic fibrosis treatment now available to children 6 years and above
6 April 2023 - From 1 May 2023, children aged 6 to 11 with cystic fibrosis will have access to ...